Posted by Michael Wonder on 14 Feb 2022
WHO prequalifies first monoclonal antibody - tocilizumab – to treat COVID-19
11 February 2022 - Aiming to increase access to recommended treatments for COVID-19, WHO today added tocilizumab, a monoclonal antibody, to its list of prequalified treatments for COVID-19.
To date, six COVID-19 treatments have been prequalified by WHO, including the three presentations (three vials, each with a different quantity) of the product prequalified today.
